CRDF: Cardiff Oncology, Inc. Stock

by  •  • Comments Off on CRDF: Cardiff Oncology, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 186.75
Enterprise Value ($M) 165.10
Book Value ($M) 69.74
Book Value / Share 1.56
Price / Book 2.68
NCAV ($M) 65.51
NCAV / Share 1.47
Price / NCAV 2.85

Profitability (mra)
Return on Invested Capital (ROIC) -0.58
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 7.41
Current Ratio 7.41

Balance Sheet (mrq) ($M)
Current Assets 77.41
Assets 81.64
Liabilities 11.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.49
Operating Income -45.41
Net Income -41.44
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.89
Cash from Investing 36.20
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-06 13G/A Acorn Bioventures, L.p. 4.20 -36.03

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 155,167 562,593 27.58
2024-04-24 77,324 301,442 25.65
2024-04-23 187,433 680,272 27.55
2024-04-22 136,538 103,412 132.03

(click for more detail)

Similar Companies
COYA – Coya Therapeutics, Inc. CPRX – Catalyst Pharmaceuticals, Inc.
CRBP – Corbus Pharmaceuticals Holdings, Inc. CRIS – Curis, Inc.
CRVO – CervoMed Inc.


Financial data and stock pages provided by
Fintel.io